Skip to content
2000
Volume 19, Issue 13
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Background: Increased rate of mortality due to the development of resistance to currently available antimicrobial and anticancer agents initiated the need to develop new chemical entities for the treatment of microbial infections and cancer. Objective: The present study was aimed to synthesize and evaluate antimicrobial and anticancer activities of Schiff bases of 2-mercaptobenzimidazole. Methods: The Schiff bases of 2-mercaptobenzimidazole were synthesized from 4-(2-(1H-benzo[d]- imidazol-2-ylthio)acetamido)benzohydrazide. The synthesized compounds were evaluated for antimicrobial and anticancer activities by tube dilution method and Sulforhodamine-B (SRB) assay, respectively. Results: Compounds 8 (MICpa, an = 2.41, 1.20 μM/ml), 10 (MICse, sa = 2.50 μM/ml), 20 (MICec = 2.34 μM/ml) and 25 (MICca = 1.46 μM/ml) showed significant antimicrobial activity against tested bacterial and fungal strains and compounds 20 (IC50 = 8 μg/ml) and 23 (IC50 = 7 μg/ml) exhibited significant anticancer activity. Conclusion: In general, the synthesized derivatives exhibited moderate antimicrobial and anticancer activities. Compounds 8 and 25 having high antifungal potential among the synthesized compounds may be taken as lead molecules for the development of novel antifungal agents.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557518666181009151008
2019-08-01
2025-07-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557518666181009151008
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test